Misbah Tahir
Director of Finance/CFO chez IGM BIOSCIENCES, INC.
Fortune : 872 534 $ au 31/03/2024
Profil
Misbah Tahir is currently the Chief Financial Officer at IGM Biosciences, Inc. Prior to this, Mr. Tahir worked as the Vice President & Head-Finance at Dermira, Inc. from 2014 to 2018.
Mr. Tahir completed an undergraduate degree at the University of Pennsylvania and an MBA from the Stephen M.
Ross School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IGM BIOSCIENCES, INC.
0,27% | 14/03/2024 | 90 418 ( 0,27% ) | 872 534 $ | 31/03/2024 |
Postes actifs de Misbah Tahir
| Sociétés | Poste | Début |
|---|---|---|
| IGM BIOSCIENCES, INC. | Director of Finance/CFO | 01/01/2019 |
Anciens postes connus de Misbah Tahir
| Sociétés | Poste | Fin |
|---|---|---|
| DERMIRA, INC. | Corporate Officer/Principal | 01/12/2018 |
Formation de Misbah Tahir
| University of Pennsylvania | Undergraduate Degree |
| Stephen M. Ross School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| IGM BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN. | Health Technology |
